Yong Rae Hong,Jeong Eun Na,Im Sook Min,Hyun Ju Cha,Sool Ki Kwon,Seonggu Ro,Joong Myung Cho
申请号：
US15691432
公开号：
US20170362205A1
申请日:
2017.08.30
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention provides a compound selected from the group consisting of a compound of formula (I), pharmaceutically acceptable salts, esters, prodrugs, hydrates, solvates and isomers thereof； a use of the compound for the treatment, relief or prevention of diseases caused by abnormal or uncontrolled activation of protein kinase, and a use of the compound for the manufacture of a medicament for the treatment, relief or prevention of the diseases； a pharmaceutical composition comprising the compound as an active ingredient； and a method for the treatment, relief or prevention of the diseases using the compound. The inventive compound is useful for the treatment, relief or prevention of diseases caused by abnormal or uncontrolled activation of protein kinase.
